|
CRKL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.53850002024581E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.08640002444349E-10 |
| Normal-vs-Stage2 |
2.785600E-02 |
| Normal-vs-Stage3 |
2.882200E-02 |
| Normal-vs-Stage4 |
2.599200E-01 |
| Stage1-vs-Stage2 |
1.812640E-01 |
| Stage1-vs-Stage3 |
1.433010E-01 |
| Stage1-vs-Stage4 |
2.637000E-01 |
| Stage2-vs-Stage3 |
9.915200E-01 |
| Stage2-vs-Stage4 |
9.095000E-01 |
| Stage3-vs-Stage4 |
9.077200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.31249999336359E-09 |
| Normal-vs-AfricanAmerican |
2.52840000047883E-08 |
| Normal-vs-Asian |
9.153200E-04 |
| Caucasian-vs-AfricanAmerican |
4.665000E-01 |
| Caucasian-vs-Asian |
7.742800E-01 |
| AfricanAmerican-vs-Asian |
9.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.15710013687465E-10 |
| Normal-vs-Female |
5.078700E-03 |
| Male-vs-Female |
7.956400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.66480999999052E-05 |
| Normal-vs-Extreme_Weight |
2.48559950399851E-10 |
| Normal-vs-Obese |
1.415590E-03 |
| Normal-vs-Extreme_Obese |
8.418200E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.668000E-01 |
| Normal_Weight-vs-Obese |
1.918800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.500400E-01 |
| Extreme_Weight-vs-Obese |
2.619900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.863200E-01 |
| Obese-vs-Extreme_Obese |
4.096200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.398000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.45590000000251E-06 |
| Normal-vs-Age(61-80Yrs) |
4.34150049244408E-10 |
| Normal-vs-Age(81-100Yrs) |
3.65220000000388E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.810440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.047910E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.036900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.868000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.922000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.042170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.61440002979896E-09 |
| Normal-VS-Type2 PRCC |
1.05849999987306E-07 |
| Normal-VS-KIRP CIMP |
8.501000E-01 |
| Normal-VS-Unclassified PRCC |
1.594800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.442200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.518000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.856000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.304190E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.702200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.369700E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62310000054278E-07 |
| Normal-vs-N1 |
4.156400E-01 |
| Normal-vs-N2 |
6.194200E-01 |
| N0-vs-N1 |
1.181160E-01 |
| N0-vs-N2 |
1.170160E-01 |
| N1-vs-N2 |
6.925600E-01 |
|
|
